This inventor holds 1 USPTO granted patent. Top assignee: Kaleido Biosciences, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Brian Meehan: Innovator in Oligosaccharide Compositions
Introduction
Brian Meehan is an innovative inventor based in Lexington, MA, who has made significant contributions to the field of biotechnology. He is known for his work at Kaleido Biosciences, Inc., where he focuses on groundbreaking research and development. With one patent to his name, his inventions aim to address critical healthcare challenges.
Latest Patents
Meehan holds a patent titled "Oligosaccharide compositions and methods of use thereof." This patent details oligosaccharide compositions and outlines methods for producing them. Furthermore, the patent highlights the application of these compositions as microbiome metabolic therapies aimed at reducing ammonia levels, along with potential treatments for related diseases. This work signifies an important advancement in therapeutic strategies.
Career Highlights
Throughout his tenure at Kaleido Biosciences, Inc., Meehan has demonstrated a commitment to research that marries innovation with practical healthcare solutions. His background in biotechnology provides a strong foundation for his inventive pursuits, focusing on addressing complex biological problems through innovative methodologies.
Collaborations
Brian collaborates with talented professionals, including Christopher Matthew Liu and Anastasia Lioubomirov. Together, they contribute to advancements in biotechnology, utilizing their collective expertise to develop and refine innovative solutions in their respective fields.
Conclusion
In summary, Brian Meehan stands out as a prominent inventor in the biotechnology sector. His patent on oligosaccharide compositions underscores his commitment to improving healthcare through innovation. As he continues his work at Kaleido Biosciences, Inc., he is set to make further contributions to the landscape of medical therapies, positioning himself as a key figure in the development of new treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
